NCT05827081 2026-03-02
Adjuvant WIDER
Novartis
Phase 3 Recruiting
Clinical Trials
3 trialsNCT02960022 2025-12-17
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Astellas Pharma Inc
Phase 2 Recruiting
NCT06490328 2024-07-08
Efficacy and Safety of DKF-MA102 in Patients With Prostate Cancer
Dongkook Pharmaceutical Co., Ltd.
Phase 3 Recruiting